TRICUSPID REGURGITATION
Clinical trials for TRICUSPID REGURGITATION explained in plain language.
Never miss a new study
Get alerted when new TRICUSPID REGURGITATION trials appear
Sign up with your email to follow new studies for TRICUSPID REGURGITATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart valve repair showdown: which surgical fix lasts longer?
Disease control Recruiting nowThis study aims to find out which of two common surgical repair techniques works better for fixing a leaky tricuspid heart valve. Researchers will compare a flexible band to a rigid ring in 300 patients who also need other heart surgery. The goal is to see which method provides m…
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: Nanjing Medical University • Aim: Disease control
Last updated Apr 01, 2026 23:11 UTC
-
New device aims to fix failing heart valves without major surgery
Disease control Recruiting nowThis early study is testing the safety and performance of a new device called the Trisol System. It is designed to treat patients with a moderate or severe leak in their tricuspid heart valve, a condition that can cause shortness of breath and fatigue. The device is implanted thr…
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: Trisol Medical • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New heart valve device offers hope for severe leaky valve patients
Disease control Recruiting nowThis study is testing a new device called the VDyne System that replaces a leaky tricuspid heart valve without open-heart surgery. Researchers will enroll 120 adults with severe valve leakage to see if the device is safe and improves symptoms, walking ability, and quality of life…
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: VDyne, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Heart valve fix could boost kidneys and strength in elderly
Disease control Recruiting nowThis study is testing if a minimally invasive procedure to fix a severely leaky heart valve (tricuspid valve) helps older adults feel better and function better. Researchers will check if the procedure improves kidney function, reduces leg swelling, increases walking ability, and…
Matched conditions: TRICUSPID REGURGITATION
Sponsor: Robert Bosch Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New heart valve implant offers hope for patients too sick for surgery
Disease control Recruiting nowThis study is testing a new device called the Cardiovalve system to treat severe tricuspid regurgitation, a serious heart valve leak. The device is delivered through a vein in the leg to replace the leaky valve without open-heart surgery. Researchers aim to show the device is saf…
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Pioneering heart valve fix tested in first patients
Disease control Recruiting nowThis is an early study to test the safety and function of a new device called the DUO System. It is designed to repair a severely leaking tricuspid heart valve using a catheter, avoiding open-heart surgery. The study will enroll 15 patients who have symptoms despite medication to…
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: CroiValve Limited • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New heart valve fix could help High-Risk patients avoid major surgery
Disease control Recruiting nowThis study is testing a new device called the PASCAL system, which is designed to repair a leaky tricuspid heart valve without open-heart surgery. It will compare the device plus standard medical care against medical care alone in about 870 patients who have severe symptoms and a…
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New heart device offers hope for High-Risk patients
Disease control Recruiting nowThis early study is testing a new device called 'Pivot Extend' for people with a severe leak in their tricuspid heart valve. It's for patients who are too high-risk for traditional open-heart surgery. The main goals are to check if the device is safe to implant and if it helps re…
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: Tau Medical Australia Pty Ltd • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
New heart valve implant trial offers hope for patients with severe leakage
Disease control Recruiting nowThis study is testing a new device called the Cardiovalve TR system, which is designed to replace a leaky heart valve (tricuspid valve). It will involve about 100 patients who have severe leakage and symptoms like shortness of breath. The main goals are to see if the procedure is…
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New heart valve procedure tested for High-Risk patients
Disease control Recruiting nowThis study is testing a new, less invasive way to replace a leaky tricuspid heart valve. Doctors will insert a replacement valve through a vein in the leg, avoiding open-heart surgery. It is for patients with severe valve leakage who are too high-risk for traditional surgery. The…
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New device aims to fix leaky heart valve without major surgery
Disease control Recruiting nowThis study is testing a new device called the VDyne System to treat a severely leaky tricuspid heart valve. The goal is to see if this less invasive procedure is safe and can improve symptoms, walking ability, and quality of life for people with this condition. The study will enr…
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: VDyne, Inc. • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Global heart valve study aims to make risky procedure safer for thousands
Disease control Recruiting nowThis global registry aims to understand the safety and effectiveness of a minimally invasive procedure to replace a leaky tricuspid heart valve. It will follow 800 patients who receive the new valve to track complications, recovery, and long-term quality of life. The goal is to i…
Matched conditions: TRICUSPID REGURGITATION
Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Pioneering heart valve fix tested in canada
Disease control Recruiting nowThis early study is testing the safety and initial performance of a new device called the Laplace System. It aims to replace a severely leaky tricuspid heart valve using a catheter inserted through a vein, avoiding open-heart surgery. The study will enroll about 15 patients in Ca…
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: Laplace Interventional, Inc • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
Berlin launches heart valve procedure registry to track patient outcomes
Knowledge-focused Recruiting nowThis study is a registry that will track 200 patients in Berlin who have had a minimally invasive procedure to fix leaky or narrowed valves on the right side of their heart. The goal is to observe and compare how different procedures affect patients' survival, need for hospital s…
Matched conditions: TRICUSPID REGURGITATION
Sponsor: Charite University, Berlin, Germany • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC